In a longitudinal clinical study to compare two groups, the primary end point is often the time to a specific event (eg, disease progression, death). The hazard ratio estimate is routinely used to ...

When analyzing clinical trial results—especially in oncology—two numbers are central to understanding a drug’s impact: the hazard ratio (HR) and the p-value. Investors often glance at p-values for a ...